Adamas Pharmaceuticals Inc·4

Oct 7, 5:27 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed Oct 7, 2015

Insider Transaction Report

Form 4
Period: 2015-10-05
Transactions
  • Sale

    Common Stock

    2015-10-05$16.75/sh3,000$50,25054,000 total
Holdings
  • Common Stock

    (indirect: Ivan Lieberburg and Janice Kirsch as CPWTROS)
    16,000
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_609216

    POA DOCUMENT